Indian firm to test anthrax vaccine
A genetically-manipulated, novel vaccine against anthrax has moved out from laboratory to undergo clinical trials by a private Indian firm. This brings the recombinant vaccine a step closer to
A genetically-manipulated, novel vaccine against anthrax has moved out from laboratory to undergo clinical trials by a private Indian firm. This brings the recombinant vaccine a step closer to